George L. Sing - Aug 6, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**George L. Sing
Stock symbol
REGN
Transactions as of
Aug 6, 2021
Transactions value $
-$4,255,877
Form type
4
Date filed
8/10/2021, 05:00 PM
Next filing
Aug 13, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale -$1.83M -3K -5.49% $611.43 51.7K Aug 6, 2021 Direct
transaction REGN Common Stock Sale -$611K -1K -1.94% $611.23 50.7K Aug 6, 2021 Direct
transaction REGN Common Stock Sale -$369K -600 -1.18% $615.00 50.1K Aug 10, 2021 Direct
transaction REGN Common Stock Sale -$614K -1K -2% $614.00 49.1K Aug 10, 2021 Direct
transaction REGN Common Stock Sale -$613K -1K -2.04% $613.01 48.1K Aug 10, 2021 Direct F1
transaction REGN Common Stock Sale -$214K -350 -9.46% $612.42 3.35K Aug 6, 2021 by Trust for Son
holding REGN Common Stock 1.15K Aug 6, 2021 by Spouse
holding REGN Common Stock 400 Aug 6, 2021 by Spouse/Cust Son
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents volume-weighted average price of sales of 1,000 shares of Company stock on August 10, 2021 at prices ranging from $613.00 to $613.05. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.